AOD-9604, a synthetic peptide derived from the growth hormone (GH) portion. This peptide, consisting of 15 amino acids, exerts its effects primarily through the regulation of fat metabolism and lipid breakdown, making it a promising candidate for the treatment of obesity and related metabolic disorders.
One of the key mechanisms through which AOD-9604 operates is its ability to mimic the action of natural GH, albeit with a more focused impact on fat metabolism. By activating the beta-adrenergic receptor, AOD-9604 stimulates the breakdown of stored fat cells, a process known as lipolysis. This selective targeting of adipose tissue makes it a valuable tool in combating excess body fat, particularly in individuals resistant to traditional weight loss interventions.
AOD-9604 has been shown to possess anti-lipogenic properties, meaning it can inhibit the formation of new fat cells while promoting the utilization of existing fat stores for energy production. This dual mechanism of action not only aids in reducing body weight but also helps prevent the accumulation of fat in tissues, thereby mitigating the risk of obesity-related complications such as insulin resistance and cardiovascular disease.
